With Flu Season Upon The Midwest, USL&H's Medical Director Provides a Synopsis on Four Prevalent Vaccines and Stresses Their Importance
With the flu season quickly approaching, United Security Life and Health Insurance Company's (USL&H) Medical Director, Leonard Hertko, M.D. outlines the guidelines and benefits of the influenza, pneumonia, shingles and whopping cough vaccines. Dr. Hertko stresses the importance of these vaccines in reducing serious illness, lost wages, and high medical bills.
Bedford Park, IL (PRWEB) October 30, 2012
With the flu season quickly approaching, United Security Life and Health Insurance Company's(USL&H) Medical Director, Leonard Hertko, M.D. outlines the guidelines and benefits of the influenza, pneumonia, shingles and whopping cough vaccines. Dr. Hertko stresses the importance of these vaccines in reducing serious illness, lost wages, and high medical bills.
“The Centers for Disease Control estimated that, on average, approximately 5% to 20% of U.S. residents get the flu, and more than 200,000 people are hospitalized for flu-related complications each year. Contracting the flu or influenza not only can result in serious and sometimes fatal health complications, but is responsible for tremendous health care costs and lost wages.” began Dr. Hertko. “In the journal Vaccine, the Center for Disease Control published a study in which dollar figures on visits to doctor's offices and emergency rooms for the treatment of flu-stricken children were recorded. It also studied the amount of time parents had to miss work and care for little ones while they recover. The study examined the experience of 282 children under the age of five in three U.S. cities, and found that parents had medical expenses ranging from under $300 to about $4,000 and missed between 11 and 73 hours of work, depending on whether their child was able to recover at home or was hospitalized,” continued Dr. Hertko.
While it is unpredictable to determine how aggressive the influenza season will be each year, obtaining influenza vaccine will reduce the likelihood that someone will contract the flu. This same principle holds true for illnesses such as pneumonia, shingles and whooping cough. Vaccines to prevent and or lessen the severity of the illness are available. Dr. Hertko outlines some basic guidelines and essential information on each of these important vaccines.
Influenza Vaccine (Flu)
- Flu vaccines are designed to protect against three influenza viruses that experts predict will be the most common during the upcoming season. Three kinds of influenza viruses commonly circulate among people today: influenza B viruses, influenza A (H1N1) viruses, and influenza A (H3N2) viruses. Each year, one flu virus of each kind is used to produce seasonal influenza vaccine.
Pneumonia Vaccine (adults)
- The pneumonia vaccine protects against13 of the most prevalent types of pneumonia.
</ul> Shingles (Zostavox)
- In a clinical trial involving thousands of adults 60 years old or older, Zostavax reduced the risk of shingles by about half (51%) and the risk of post-herpetic neuralgia by 67%. While the vaccine was most effective in people 60-69 years old it also provided some protection for older groups.
</ul> Whooping cough (Tdap)
- The whooping cough booster vaccine for adolescents and adults is called Tdap. Both protect against whooping cough, tetanus, and diphtheria. The childhood vaccine is called DTaP.
About United Security Life and Health Insurance Company:
USL&H is a regional insurance carrier that offers a variety of Health and Life insurance products, as well as Disability Income, Critical Illness, Cancer, Accident Hospital Indemnity, and a Dental Plus Vision and Hearing product to individuals and families. Founded in 1973, USL&H is licensed to sell its products in Arizona, Arkansas, Illinois, Indiana and Missouri and Nebraska through a network of independent insurance agents. For more information on United Security Life and Health Insurance Company please visit the company's website at http://www.uslandh.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/10/prweb9947135.htmView Comments and Join the Discussion!